UNICYCIVE THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Prepaid Expense and Other Assets, Current of $9.89 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $9.89M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $8.96M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $7.69M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $7.59M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $9.89M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $8.96M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $7.69M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.59M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $7.20M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $7.58M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.81M 10-K · filed 2026-03-30 |
| 2024-09-30 | $5.39M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.27M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.75M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.70M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.22M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.11M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $2.19M 10-K · filed 2024-03-28 |
| 2021-12-31 | $1.83M 10-K · filed 2022-03-31 |
| 2021-09-30 | $1.71M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $4.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |